Opthea Appoints John Han, PharmD, as VP Medical Affairs
Brings extensive experience in retinal and ophthalmology diseases Brings extensive experience in retinal and ophthalmology diseases
Opthea Appoints John Han, PharmD, as VP Medical Affairs
Ähnliche Beiträge
Foresee Pharmaceuticals Receives Positive Recommendation from DSMB to Continue Pjhase 3 Casppian Study
Foresee Pharmaceuticals (TPEx: 6576), („Foresee“) today announces the positive safety review by the independent Data and Safety Monitoring Board for its Casppian Phase 3 registration study. The DSMB recommended that Foresee Pharmaceuticals continue the trial with a minor amended protocol. The Casppian Phase 3 study is an open-label, multicenter, multinational clinical trial to evaluate the efficacy,…
Rice breakthrough could make automated dosing systems universal
HOUSTON – Rice University synthetic biologists have found a way to piggyback on the glucose monitoring technology used in automated insulin dosing systems and make it universally applicable for the monitoring and dosing of virtually any drug. In a recently published study in Nature Communications, researchers in the lab of Caroline Ajo-Franklin demonstrated the technique…
Messer nimmt erfolgreich 1,1 Milliarden US-Dollar in Private Placement auf
Messer, der weltweit führende Spezialist für Industrie-, Medizin- und Spezialgase in Privatbesitz, hat in einer Privatplatzierung 1,1 Milliarden US-Dollar bei institutionellen Investoren aufgenommen. Die Erlöse wurden hauptsächlich für die vollständige Refinanzierung eines US-Dollar-Akquisitionskredits verwendet, den Messer für den Erwerb aller Anteile an Messer Industries vom Minderheitseigentümer CVC Capital Partners im vergangenen Jahr aufgenommen hatte. Die…
Identification of GPR35-associated metabolic characteristics through LC-MS/MS-based metabolomics and lipidomics
Announcing a new publication for Acta Materia Medica journal. G protein-coupled receptor 35 (GPR35) has gained increasing attention as a promising target in treating inflammatory and gastrointestinal tract conditions, cardiovascular diseases, and cancer. Metabolites including kynurenic acid, lysophosphatidic acids, chemokine 17, and 5-hydroxyindole acetic acid have been suggested to be endogenous ligands of GPR35. However,…
ARS Pharma Announces Favorable Topline Results from Repeat Dosing Study of neffy® (Epinephrine Nasal Spray) Under Nasal Allergen Challenge Conditions, Readies Data for Response to FDA’s Complete Response Letter
Repeat doses of neffy under nasal allergen challenge demonstrate a pharmacokinetic profile greater than or similar to injection, and a pharmacodynamic profile greater than injection The post ARS Pharma Announces Favorable Topline Results from Repeat Dosing Study of neffy® (Epinephrine Nasal Spray) Under Nasal Allergen Challenge Conditions, Readies Data for Response to FDA’s Complete Response……
Schweiz ist erneut Patentweltmeisterin
Aus der Schweiz sind 2023 insgesamt 9410 Patente beim Europäischen Patentamt angemeldet worden. Damit bleibt das Land weiterhin globaler Spitzenreiter bei der Zahl der Patentanmeldungen pro Kopf. Zudem wurden so viele Schweizer Patente wie nie zuvor angemeldet. Im vergangenen Jahr wurden beim Europäischen Patentamt (EPA) insgesamt 199’275 Patente angemeldet, informiert das EPA in einer […]…